ArticlePloS one2025
Identifying what matters to adults with mobility limitations regarding their experiences with medications: A concept mapping study.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDespite the high prevalence of medication use among persons with mobility limitations, there are currently no patient-reported measures that have been co-developed to assess the experiences of medications in everyday life. Therefore, the objective of this study was to develop potential items for a patient-reported experience measure related to medication use for adults with mobility limitations.
methodsWe conducted a concept mapping study with people with mobility limitations. Participants were required to: be 18 years of age or older, live in Canada, live in the community, speak, and read English or French, have a mobility limitation, and take at least one medication recommended by a prescriber in the preceding three months. Participants generated statements in response to the focal prompt: what matters to you about medications in your everyday life? Participants then sorted piles of statements based on their conceptual similarity, rated each statement on two dimensions (importance and realistic), and created visual maps of the data.
resultsA total of 45 individuals participated in at least one step of the concept mapping. Participants generated 694 statements which were synthesized into 80 unique statements. The final map contained ten clusters: (1) medication-related financial considerations and support; (2) pharmacy-related services and supports; (3) access to medications and medication-related supports; (4) acceptance and stigma around medication use; (5) ability and ease of taking medications; (6) shared decision-making and access to medication-related research and information; (7) medication effectiveness, side effects and risks; (8) knowledge, self-awareness and empowerment; (9) accessibility of healthcare providers; and (10) communication and relationships with healthcare providers.
conclusionsIn this participatory-based research, we have identified key items and domains related to medication-related experiences. Understanding what matters to patients will support quality improvement of healthcare delivery and outcomes for adults with mobility limitations who take medications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.